Sloan Sheldon 4
4 · Spyre Therapeutics, Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Sloan Sheldon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+140,000→ 140,000 totalExercise: $30.61Exp: 2036-01-09→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 140,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact|2026-01-13